商品名或批准名。第四部分。解决方案。处方开具与制剂监管。
Trade names or approved names. Part IV. The solution. Prescribing and the regulation of formulation.
作者信息
Beckett A H
出版信息
Postgrad Med J. 1974 Feb;50(580):125-9. doi: 10.1136/pgmj.50.580.125.
Abstract
Unless the equivalence of different products has been established, the prescriber must define the product he requires by using the trade name. Present pharmacopoeial standards based on methods are inadequate to predict equivalence in man. There are many ways in which differences in formulation may influence absorption of drugs, and only comparable absorption profiles can be taken as evidence of equivalence.
摘要
除非已确定不同产品的等效性，否则开处方者必须使用商品名来明确其所需的产品。目前基于方法的药典标准不足以预测人体中的等效性。制剂方面的差异可能会通过多种方式影响药物吸收，只有可比的吸收曲线才能作为等效性的证据。
相似文献
1
Trade names or approved names. Part IV. The solution. Prescribing and the regulation of formulation.商品名或批准名。第四部分。解决方案。处方开具与制剂监管。
Postgrad Med J. 1974 Feb;50(580):125-9. doi: 10.1136/pgmj.50.580.125.
2
Trade names or approved names. Point II. Points of view. The clinical pharmacologist.商品名或批准名。第二点。观点。临床药理学家。
Postgrad Med J. 1974 Feb;50(580):93-5. doi: 10.1136/pgmj.50.580.93.
3
Trade names or approved names. Part III. Special cases. The digoxin affair.商品名或批准名。第三部分。特殊情况。地高辛事件。
Postgrad Med J. 1974 Feb;50(580):98-102. doi: 10.1136/pgmj.50.580.98.
4
Trade names or approved names. Part IV. The solution. Introduction.
Postgrad Med J. 1974 Feb;50(580):121. doi: 10.1136/pgmj.50.580.121.
5
Trade names or approved names. Part II. Points of view. Europe.
Postgrad Med J. 1974 Feb;50(580):73-6. doi: 10.1136/pgmj.50.580.73.
6
Trade names or approved names. Part II. Points of view. The pharmaceutical company.商品名或批准名。第二部分。观点。制药公司。
Postgrad Med J. 1974 Feb;50(580):85-7. doi: 10.1136/pgmj.50.580.85.
7
Trade names or approved names. Part III. Special cases. Clinical trials.商品名或批准名。第三部分。特殊情况。临床试验。
Postgrad Med J. 1974 Feb;50(580):114-20. doi: 10.1136/pgmj.50.580.114.
8
Trade names or approved names. Part III. Special cases. Antibiotics.商品名或批准名。第三部分。特殊情况。抗生素。
Postgrad Med J. 1974 Feb;50(580):96-7. doi: 10.1136/pgmj.50.580.96.
9
Trade names or approved names. Part III. Special cases. Anti-diabetic drugs.商品名或批准名。第三部分。特殊情况。抗糖尿病药物。
Postgrad Med J. 1974 Feb;50(580):112-3. doi: 10.1136/pgmj.50.580.112.
10
Trade names or approved names. Part III. Special cases. Combination products.商品名或批准名。第三部分。特殊情况。组合产品。
Postgrad Med J. 1974 Feb;50(580):103-6. doi: 10.1136/pgmj.50.580.103.
Zotero 插件